Skip to main content
Clinical Trials/JPRN-UMIN000046004
JPRN-UMIN000046004Recruiting未知

Angiotensin receptor-neprilysin inhibitor in patients with acute myocardial infarction and heart failure - Acute MI and HF registry in Chiba

Chiba University Hospital0 sites1,000 target enrollmentStarted: December 1, 2021Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Recruiting
Enrollment
1,000

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
ot applicable to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1) Maintenance hemodialysis 2) eGFR <30 ml/min/1.73 m2 3) Failed PCI (TIMI flow grade 0 or 1) 4) In-hospital death

Investigators

Similar Trials

Completed
Not Applicable
Angiotensin Receptor-Neprilysin Inhibitor (ARNI) and Cancer Risk: A systematic review and network meta-analysisHypertension, Coronary artery disease, Heart failure, Chronic kidney disease, Atrial fibrillation, High risk vascular disease, Cerebrovascular accident, Diabetes mellitus, High normal blood pressure, Pre-hypertension
JPRN-UMIN000048395Yokohama City University Graduate School of Medicine
Recruiting
Unknown
The effect of an angiotensin receptor-neprilysin inhibitor to blood pressure and sympathoadrenal responses during mental arithmetic stress in patients with essential hypertensioessential hypertension
JPRN-UMIN000051537niversity of Toyama40
Active, not recruiting
Phase 1
Effect of the drug sacubitril/valsartan on physical performance in patients with hypertrophic cardiomyopathyhypertrophic cardiomyopathy
EUCTR2018-004882-15-DEniversity Hospital Regensburg40
Active, not recruiting
Phase 1
Influences of Sacubitril/Valsartan (ENTRESTO®) on centrally generated sympathetic activity in heart failure patientsChronic heart failure with reduced left ventricular ejection fraction (NYHA II-III)MedDRA version: 20.0Level: LLTClassification code 10078289Term: Heart failure with reduced ejection fractionSystem Organ Class: 100000004849
EUCTR2017-000394-36-DEHannover Medical School35
Not yet recruiting
Not Applicable
Effect of angiotensin receptor blockers for neointimal coverage after stent implantation.Hypertensive patients with coronary arteries disease.
JPRN-UMIN000007634Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine70